SOLV Solventum

company

SEC Filings & Insider Trading Activity 2026

Business Overview

• • Global healthcare company (~20,000 employees, ~$0 revenue figures disclosed) across three segments: MedSurg 57.9%, Health Information Systems 16.3%, Dental Solutions 16.2% of 2025 sales
• • Two major portfolio moves in 2025: acquired Acera Surgical (bioscience, adds synthetic tissue matrices) and divested Purification & Filtration business to Thermo Fisher Scientific

Management Discussion & Analysis

• • Revenue $8,325M, up 0.9% YoY ($71M increase); organic growth 3.3%, offset by -3.0% divestiture impact from Purification & Filtration sale
• • Operating margin 26.2% vs 12.6% in 2024 (includes $1.5B gain on P&F sale); SG&A 37.0% vs 33.7%; R&D 8.9% vs 9.4%

Risk Factors

• • 3M sole-source supplier for materials tied to ~$3B revenue (FY2025); ~$2B from proprietary material with no identified substitute or internal manufacturing capability
• • $5B outstanding debt post-spin as of Dec 31, 2025; constrains capital allocation, raises downgrade risk, and limits strategic flexibility

Management Discussion & Analysis

• • Total revenue $2,096M Q3 2025, up 0.7% YoY from $2,082M Q3 2024, organic growth 2.7%, adjusted for divestitures and currency
• • Operating margin 80.6% Q3 2025 vs 13.2% Q3 2024, driven largely by $1.5B gain on sale of Purification and Filtration business

Risk Factors

• • No new or changed risk factors since 2024 10-K
• • Continued risks from supply chain disruptions impacting production timelines

What are the latest SOLV SEC filings in 2026?

Solventum (SOLV) has filed a 10-K annual report on February 27, 2026, a 10-Q quarterly report on November 6, 2025, an 8-K current report on March 24, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did SOLV file its most recent 10-K annual report?

Solventum (SOLV) filed its most recent 10-K annual report on February 27, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view SOLV 10-Q quarterly reports?

Solventum (SOLV)'s most recent 10-Q quarterly report was filed on November 6, 2025. SignalX displays every SOLV 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has SOLV filed recently?

Solventum (SOLV)'s most recent 8-K was filed on March 24, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find SOLV insider trading activity (Form 4)?

SignalX aggregates every SOLV Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does SOLV file with the SEC?

Solventum (SOLV) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new SOLV filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Solventum (SOLV).

What is SOLV's SEC CIK number?

Solventum (SOLV)'s SEC CIK (Central Index Key) number is 1964738. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1964738 to look up all SOLV filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Where can I find SOLV return on equity (ROE) and financial data?

SignalX extracts XBRL financial data from Solventum (SOLV) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.